N4 Pharma Plc (AIM: N4P), the specialist pharmaceutical company developing Nuvec, a novel delivery system for cancer treatments and vaccines, is pleased to announce that at its annual general meeting ('AGM'), held earlier today, all resolutions were duly passed.

Contact:

Tel: +44(0)20 3470 0470

About N4 Pharma

N4 Pharma is a specialist pharmaceutical company developing a novel delivery system for cancer and vaccine treatments using its unique silica nanoparticle delivery system called Nuvec.

N4 Pharma's business model is to partner with companies developing novel antigens for cancer and vaccine treatments to use Nuvec as the delivery vehicle to get their antigen into cells to express the protein needed for the required immunity. As these products progress through pre clinical and clinical programs, N4 Pharma will seek to receive up front payments, milestone payments and ultimately royalty payments once products reach the market.

(C) 2021 Electronic News Publishing, source ENP Newswire